No company affiliations.
Business development professional with a passion for entrepreneurship and life sciences. Founder of Bioverge, an accredited investor platform helping investors discover, fund, and support the most promising life science startups. Angel investor. Derivatives trader. Reformed I-banker.
Bioverge is an online seed stage venture capital fund and angel investor platform. We help investors and corporate partners discover, fund, and support the most promising life sciences and health-tech startups.
With AUM of $3 billion, the California Institute for Regenerative Medicine (CIRM) provides funding for the translation and clinical development of novel stem cell technologies. I also manage CIRM’s infrastructure programs and am leading the effort to establish a new $150 million public-private partnership. Frequently invited speaker and panelist at scientific and business development conferences.
Venture capital firm and boutique investment bank with >$1 billion AUM. Capital raising and investing experience includes both public and private financings (IPO, follow-on, registered direct, PIPE, and early stage venture deals).
Co-founder of Brickford - hedge fund dedicated to trading equity index options. Engaged in managing all aspects of the portfolio, including overall trading strategy, risk management, and trade execution.
Responsibilities included financial modeling for buy-side and sell-side M&A, as well as analyzing capital raising alternatives for U.S. publicly traded companies.
Responsibilities included financial modeling for buy-side and sell-side M&A, as well as analyzing capital raising alternatives (both equity and debt) for U.S. and International publicly traded companies.